Pharmacist

In many villages, the pharmacy is the first door people push open when health worries set in, all the more so where the doctor's practice has closed. AI will not counsel at the counter in the pharmacist's place: it will hand back the hours that paperwork and stock shortages used to take, so they can be reinvested in that first point of contact.

The profession today

The neighbourhood pharmacy occupies a place that health statistics describe poorly: people walk in without an appointment, without a deductible to advance, often before they dare call the doctor. In towns where the practice has closed with no successor, it becomes, in effect, the health system's first point of contact. The legal framework has followed suit: vaccination at the pharmacy, dispensing certain medicines after a consultation, polymedication reviews — the scope of services has been widening for several years.

A community pharmacist's day splits across very different registers:

• Checking and dispensing prescriptions: reviewing interactions, dosages, duplications between prescribers, a final check before the medicine crosses the counter
• Counter consultation: symptoms to treat on the spot, situations to refer to the doctor or the emergency room, self-medication to be guided
• Health services: vaccinations, polymedication reviews, chronic-patient follow-up, screenings
• Stock and shortage management: orders, increasingly frequent shortages, searching for alternatives, calls to wholesalers and fellow pharmacists
• Administration: billing insurers, third-party payment, documenting services, correspondence
• Regional on-call duty: night and weekend shifts, shared among the pharmacies of a region
• Team management: associate pharmacists, pharmacy assistants, apprentices

Supply shortages, now chronic nationwide, have added a job within the job: hours each week spent tracking down what is missing, substituting, reassuring. That time cures no one.

What AI is preparing

Assisted prescription checking. Drug interactions cross-checked against the patient's history, dosages outside the norm, duplications between prescribers: the tool flags, prioritises, documents. The decision to dispense remains an act of the pharmacist, who carries the responsibility of being the last line of defence before the medicine reaches the patient's hand. A well-tuned alert system frees up attention for the cases that deserve it; poorly tuned, it drowns the signal in noise — and that tuning is itself professional work.

Compressed administration. Billing, correspondence with insurers, documenting services: on these documentary tasks, the factor of four to five observed by the author applies fully. The hours regained have an obvious destination: the health services the legal framework already permits and that lack of time used to rule out — vaccination, consultations, chronic-patient follow-up.

Pre-briefed stock and shortages. Anticipating shortages from supply signals, proposed equivalences, order preparation: the tool briefs the case. The decision to substitute, though, weighs pharmaceutical equivalence against what the pharmacist knows of the patient: their adherence to treatment, their tolerance for change, what their doctor will accept.

Equipped chronic-patient follow-up. Consolidated medication plans, renewal reminders, consultation preparation: for patients on multiple medications, the tool keeps track of what used to scatter across several prescribers and years of prescriptions. The consultation itself remains a conversation.

Health data: the prerequisite

The pharmacist is bound by professional secrecy under Article 321 of the Criminal Code, on the same footing as the doctor, and the nFADP, in force since 1 September 2023, classifies health data among sensitive personal data. Three requirements before any deployment: hosting in Switzerland, with subcontracting agreements that document who accesses what; a strict ban on feeding a medication history into a free consumer-grade tool; traceability of every alert and every validation (who saw it, who decided, when). A single pharmacy holds the medication histories of an entire village. That concentration demands the same rigour as a doctor's practice.

What rises in judgment

The last line of defence. A prescription checked by the tool and then countersigned remains a binding act: an alert wrongly dismissed and an alert wrongly followed both carry a cost. Distinguishing the theoretical interaction from the one clinically relevant to this patient, calling the prescriber when doubt persists, dispensing with a clear instruction: this discernment gains value as the volume of alerts grows.

The eye at the counter. Perceiving the person behind the prescription: an elderly patient's confusion in front of a new dosing schedule, the hesitation of someone returning a third time for a sleeping pill, the question asked quietly once the other customers have left. No medication history captures that. The time freed by automation is reinvested exactly there.

First-line triage. Advising on the spot, referring to the doctor, directing to the emergency room: this triage, exercised dozens of times a week, takes on new weight where the doctor's practice is missing. Triage that is too cautious clogs an already strained system; triage that is too confident takes a clinical risk. The pharmacist calibrates, and documents.

Shortage arbitration. When a medicine is durably unavailable, deciding who is served first, what alternative to offer, how to manage what remains: these decisions blend pharmacology, fairness and knowledge of patients. The tool draws up the state of stocks and equivalences. The arbitration itself is human.

Running an expanded pharmacy. Delegating to pharmacy assistants what written protocols allow to be delegated, organising new services, remaining accountable for the whole: the 2030 pharmacy looks more like a small care structure than a regulated shop, and running such a care team is a skill that is learned.

Who keeps the final word?

Composite illustration. A village pharmacy sees its footfall change after the retirement of the town's last doctor: more questions at the counter, more ambiguous situations. It rolls out assisted prescription checking and pre-briefed shortage management, and hands the administrative preparation of polymedication reviews to a trained assistant. The freed-up time funds a weekly half-day of vaccination and appointment-based consultations; the owner formalises a simple referral protocol with doctors in neighbouring towns, so counter triage rests on written criteria. The pharmacy absorbs the overflow without lengthening its days. (Fictional, composite scenario; to be replaced with a real case during the embodiment pass.)

2030 job profile

The first new competency is accountable alert validation: setting the system's thresholds, telling signal from noise, tracing every dispensing decision, resisting the alert fatigue that stalks any professional facing hundreds of signals a day. The last line of defence is only as good as the attention of whoever holds it.

The second is managing clinical services: vaccination, consultations, chronic-patient follow-up, screenings, along with the protocols, delegation and billing that go with them. The time freed by automation only converts into public health if the pharmacy knows how to organise these services, and that organisation is largely learned outside standard pharmacy curricula.

The third is governing health data at the pharmacy: choosing tools compliant with Article 321 CC and the nFADP, documenting data flows, training the team, informing patients. In an independent pharmacy with no IT department, this responsibility falls squarely on the owner.

Territorial anchoring

The pharmacy network is one of the last health networks still covering the whole territory: where practices close, the pharmacy often remains the only health venue accessible without an appointment. One Valaisan in ten will be over 80 by 2035, and it is precisely elderly, multi-medicated, less mobile patients who need a counter less than half an hour away and a pharmacist who knows their treatment year after year. The augmented pharmacy — assisted validation, expanded services, first-line triage coordinated with the remaining doctors — is the form this network can take to hold in the valleys. Regional on-call duty follows the same logic: every pharmacy that closes adds weight to every other's rotation, and the time freed by automation is part of what keeps that duty bearable.

What the decision-maker must do now

For a pharmacy owner

Start with administration and stock, the surest and clinically least sensitive gains: measure over a quarter the time regained, then decide as a team what it funds — a vaccination slot, polymedication reviews, better-prepared on-call duty. Then introduce assisted validation, with a written rule: every dismissed alert gets documented. Involve pharmacy assistants from the start; their roles change first.

For the cantonal pharmacists' association

Establish an industry framework: a list of tools vetted against Article 321 CC and nFADP criteria, shared experience across pharmacies, a clear public position on the traceability of validations. Also push for fee recognition of the triage and follow-up work the counter already absorbs in towns short of doctors: that work exists, and remains largely invisible in current remuneration.

For the Public Health Service

Count pharmacies in primary-care planning, on the same footing as practices: map what the pharmacy network already absorbs in doctorless towns, clarify hosting and traceability requirements for health data, and support the expansion of pharmacy services wherever it shortens the distance between an elderly patient and the health system.

---

Jérôme Deshaie is the founder of MCVA Consulting SA, an agency specialising in the AI transformation of organisations in Valais, and the author of Bisse Cognitif.